Cancer Research UK Health Behaviour Research Centre, Department of Epidemiology and Public Health, UCL, Gower Street, London, WC1E 6BT, UK.
Vaccine. 2012 Jun 22;30(30):4505-10. doi: 10.1016/j.vaccine.2012.04.066. Epub 2012 May 3.
The United States' Centers for Disease Control and Prevention recommends that boys aged 11-12 be vaccinated against HPV to reduce the risk of genital warts and HPV-related cancers. No recommendation has been made in England although there have been calls to widen access to the vaccine. This study aimed to assess boys' willingness to have HPV vaccination, eliciting reasons for their decisions.
528 boys aged 16-18 years completed a questionnaire in school. Measures included demographic characteristics, HPV awareness, willingness to have the vaccine, and reasons for the vaccine decision. Coding of open responses was informed by social cognition model constructs.
A large proportion of the sample (41%) intended to have the vaccine, however, slightly more were unsure (49%) and a small number (10%) would not get vaccinated. Uncertainty was associated with lack of previous awareness of HPV and perceived lack of adequate information. Boys who would not have the vaccine did not feel at risk or did not see the need for it.
These preliminary data suggest that HPV vaccination may be acceptable to boys, and confirm previous findings that information is vital in the decision-making process.
美国疾病控制与预防中心建议 11-12 岁的男孩接种 HPV 疫苗，以降低生殖器疣和 HPV 相关癌症的风险。尽管有人呼吁扩大疫苗接种范围，但英国尚未提出相关建议。本研究旨在评估男孩接种 HPV 疫苗的意愿，并探讨他们做出决定的原因。
528 名 16-18 岁的男孩在学校完成了一份问卷。测量指标包括人口统计学特征、HPV 认知、接种疫苗的意愿以及疫苗决策的原因。开放式回答的编码以社会认知模型构念为依据。
样本中的很大一部分（41%）表示打算接种疫苗，但也有相当一部分（49%）表示不确定，少数（10%）表示不会接种疫苗。不确定性与缺乏对 HPV 的先前认知以及认为缺乏足够信息有关。不打算接种疫苗的男孩认为自己没有感染风险，或者认为没有接种疫苗的必要。
这些初步数据表明 HPV 疫苗可能对男孩是可接受的，并证实了之前的研究结果，即信息在决策过程中至关重要。
